DUBLIN, IRELAND--(Marketwire - May 29, 2008) - Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, announced that it has retained Lytham Partners, LLC to conduct a full-scale national investor relations programme.
